ReShape Lifesciences Inc
RSLS5.920USD
-0.550-8.50%
Close 05/20, 16:00（ET）Quotes delayed by 15 min
4.32MMarket Cap
LossP/E TTM
More Details of ReShape Lifesciences Inc Company
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The Diabetes Bloc-Stim Neuromodulation system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0 FLEX, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Company Info
Company codeRSLS
Company nameReShape Lifesciences Inc
IPO dateOct 06, 2016
Founded at2008
CEOMr. Paul F. Hickey
Number of employees17
Security typeOrdinary Share
Fiscal year-endOct 06
Address1001 Calle Amanecer
CitySAN CLEMENTE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code92673
Phone19494296680
Websitehttps://www.reshapelifesciences.com/obalon/
Company codeRSLS
IPO dateOct 06, 2016
Founded at2008
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas (Tom) Stankovich
Mr. Thomas (Tom) Stankovich
Chief Financial Officer
Chief Financial Officer
16.00
--
Mr. Paul F. Hickey
Mr. Paul F. Hickey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Arda M. Minocherhomjee ,Ph.D.
Arda M. Minocherhomjee ,Ph.D.
Independent Director
Independent Director
--
--
Mr. Dan W. Gladney
Mr. Dan W. Gladney
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas (Tom) Stankovich
Mr. Thomas (Tom) Stankovich
Chief Financial Officer
Chief Financial Officer
16.00
--
Mr. Paul F. Hickey
Mr. Paul F. Hickey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Arda M. Minocherhomjee ,Ph.D.
Arda M. Minocherhomjee ,Ph.D.
Independent Director
Independent Director
--
--
Mr. Dan W. Gladney
Mr. Dan W. Gladney
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
No Data
By RegionUSD
Name
Revenue
Proportion
United States
2.01M
87.65%
Europe
168.00K
7.33%
Australia
111.00K
4.84%
Rest of World
4.00K
0.17%
By Business
By Region
No Data
Shareholder
Update time: Sat, May 17
Update time: Sat, May 17
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Leonite Fund I LP
1.08%
FirstFire Global Opportunities Fund LLC
1.08%
Bigger Capital Funds, LP
0.87%
District 2 Capital LP
0.87%
UBS Financial Services, Inc.
0.30%
Other
95.80%
Shareholder Statistics
Shareholder
Proportion
Leonite Fund I LP
1.08%
FirstFire Global Opportunities Fund LLC
1.08%
Bigger Capital Funds, LP
0.87%
District 2 Capital LP
0.87%
UBS Financial Services, Inc.
0.30%
Other
95.80%
Type
Shareholder
Proportion
Corporation
2.30%
Hedge Fund
1.93%
Investment Advisor
0.36%
Individual Investor
0.20%
Investment Advisor/Hedge Fund
0.06%
Other
95.13%
Institutional Shareholding
Update time: Tue, Mar 4
Update time: Tue, Mar 4
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
41
812.08K
7.20%
+762.12K
2024Q4
36
92.62K
3.05%
+33.67K
2024Q3
40
51.79K
41.95%
-7.67K
2024Q2
37
52.29K
38.14%
-3.61K
2024Q1
40
50.20K
37.62%
-6.41K
2023Q4
40
53.11K
38.38%
+43.81K
2023Q3
41
10.13K
39.05%
+5.49K
2023Q2
42
5.11K
36.27%
+1.18K
2023Q1
51
5.76K
66.25%
+4.13K
2022Q4
47
1.01K
13.17%
-665.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Leonite Fund I LP
200.00K
1.77%
+200.00K
--
Feb 18, 2025
FirstFire Global Opportunities Fund LLC
200.00K
1.77%
+200.00K
--
Feb 18, 2025
Bigger Capital Funds, LP
160.00K
1.42%
+160.00K
--
Feb 18, 2025
District 2 Capital LP
160.00K
1.42%
+160.00K
--
Feb 18, 2025
UBS Financial Services, Inc.
17.66K
0.16%
+17.66K
+1.77M%
Dec 31, 2024
Schneid (Yair)
37.41K
0.33%
-5.02K
-11.84%
Sep 23, 2024
Dominion Capital LLC
25.28K
0.22%
--
--
Feb 18, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Sep 19, 2024
Merger
58<1
Sep 19, 2024
Merger
58<1
Sep 19, 2024
Merger
58<1
Sep 19, 2024
Merger
58<1
Dec 22, 2022
Merger
50<1
Dec 22, 2022
Merger
50<1
Date
Type
Ratio
Sep 19, 2024
Merger
58<1
Sep 19, 2024
Merger
58<1
Sep 19, 2024
Merger
58<1
Sep 19, 2024
Merger
58<1
Dec 22, 2022
Merger
50<1
Dec 22, 2022
Merger
50<1
Dec 22, 2022
Merger
50<1
Dec 22, 2022
Merger
50<1
Jun 15, 2021
Merger
3<1
Jun 15, 2021
Merger
3<1
View more
